Jump to page content

Breaking away from traditional conference forma changes in the World Café sessions. These sessions provided a unique platform for open discussions on critical questions surrounding patient-centered ATMP development, whereby keynote lecture on the Mayo Clinic experience of implementing ATMPs in daily patient care by Atta Behfar, Director of Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program, formed the framework of the event.

The event saw enthusiastic participation from a diverse group of stakeholders, including industry experts, academic researchers, patients, and regulatory authorities. This mix of perspectives enriched the conversations, ensuring a holistic view of the challenges and opportunities in ATMP development.

The main goal of the forum was to explore innovative ways to create an optimal environment for ATMP development, with a strong focus on patient needs and perspectives. The discussions aimed to identify actionable strategies that prioritize patient welfare while advancing the field of personalized medicine.

As a tangible outcome of the event, the organizer team around Timo-Nazari-Shafti plans to compile the insights and recommendations from the discussions into a White Paper and to include the insights in the national strategy for gene and cell therapy. These documents will be made public, serving as a valuable resource for guiding future efforts in patient-centric ATMP development.

The RegMed forum marked a significant step toward fostering collaboration and understanding among key players in the healthcare sector. By centering the conversation on patients, the event highlighted the importance of empathy and inclusivity in medical research and therapy development.